LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 90

Search options

  1. Article ; Online: The Intersection of Cardiovascular Health and Maternal Health: Portfolio Analysis of Federal Grant Funding 2016-2021.

    Addou, Ebyan / Rossouw, Jacques E / Bandettini, W Patricia / Varagic, Jasmina / Wei, Gina S

    Journal of women's health (2002)

    2024  

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2024-04-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1139774-3
    ISSN 1931-843X ; 1059-7115 ; 1540-9996
    ISSN (online) 1931-843X
    ISSN 1059-7115 ; 1540-9996
    DOI 10.1089/jwh.2023.0750
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Obesity: A Perspective from Hypertension.

    Susic, Dinko / Varagic, Jasmina

    The Medical clinics of North America

    2017  Volume 101, Issue 1, Page(s) 139–157

    Abstract: The prevalence of obesity-related hypertension is high worldwide and has become a major health issue. The mechanisms by which obesity relates to hypertensive disease are still under intense research scrutiny, and include altered hemodynamics, impaired ... ...

    Abstract The prevalence of obesity-related hypertension is high worldwide and has become a major health issue. The mechanisms by which obesity relates to hypertensive disease are still under intense research scrutiny, and include altered hemodynamics, impaired sodium homeostasis, renal dysfunction, autonomic nervous system imbalance, endocrine alterations, oxidative stress and inflammation, and vascular injury. Most of these contributing factors interact with each other at multiple levels. Thus, as a multifactorial and complex disease, obesity-related hypertension should be recognized as a distinctive form of hypertension, and specific considerations should apply in planning therapeutic approaches to treat obese individuals with high blood pressure.
    MeSH term(s) Autonomic Nervous System/physiopathology ; Endocrine System/physiopathology ; Hemodynamics ; Humans ; Hypertension/drug therapy ; Hypertension/etiology ; Hypertension/physiopathology ; Obesity/complications ; Obesity/physiopathology ; Oxidative Stress ; Sodium/metabolism
    Chemical Substances Sodium (9NEZ333N27)
    Language English
    Publishing date 2017-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 215710-x
    ISSN 1557-9859 ; 0025-7125
    ISSN (online) 1557-9859
    ISSN 0025-7125
    DOI 10.1016/j.mcna.2016.08.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Edward D. Frohlich, MD: September 10, 1931-August 16, 2019.

    Ferrario, Carlos M / Varagic, Jasmina / Navar, Luis Gabriel / Re, Richard N / Ventura, Hector O

    Hypertension (Dallas, Tex. : 1979)

    2019  Volume 74, Issue 6, Page(s) 1229–1231

    Language English
    Publishing date 2019-11-04
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 423736-5
    ISSN 1524-4563 ; 0194-911X ; 0362-4323
    ISSN (online) 1524-4563
    ISSN 0194-911X ; 0362-4323
    DOI 10.1161/HYPERTENSIONAHA.119.13883
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms.

    Rahimi, Omeed / Kirby, Jay / Varagic, Jasmina / Westwood, Brian / Tallant, E Ann / Gallagher, Patricia E

    American journal of physiology. Heart and circulatory physiology

    2020  Volume 318, Issue 4, Page(s) H883–H894

    Abstract: Doxorubicin (Dox) is an effective chemotherapeutic for a variety of pediatric malignancies. Unfortunately, Dox administration often results in a cumulative dose-dependent cardiotoxicity that manifests with marked oxidative stress, leading to heart ... ...

    Abstract Doxorubicin (Dox) is an effective chemotherapeutic for a variety of pediatric malignancies. Unfortunately, Dox administration often results in a cumulative dose-dependent cardiotoxicity that manifests with marked oxidative stress, leading to heart failure. Adjunct therapies are needed to mitigate Dox cardiotoxicity and enhance quality of life in pediatric patients with cancer. Angiotensin-(1-7) [Ang-(1-7)] is an endogenous hormone with cardioprotective properties. This study investigated whether adjunct Ang-(1-7) attenuates cardiotoxicity resulting from exposure to Dox in male and female juvenile rats. Dox significantly reduced body mass, and the addition of Ang-(1-7) had no effect. However, adjunct Ang-(1-7) prevented Dox-mediated diastolic dysfunction, including markers of decreased passive filling as measured by reduced early diastole mitral valve flow velocity peak (
    MeSH term(s) Angiotensin I/therapeutic use ; Animals ; Antineoplastic Agents/toxicity ; Antioxidants/therapeutic use ; Cardiotoxicity ; Catalase/metabolism ; Doxorubicin/toxicity ; Female ; Heart Diseases/drug therapy ; Heart Diseases/etiology ; Heart Rate ; Male ; Malondialdehyde/metabolism ; Mitral Valve/physiopathology ; Myocardium/metabolism ; NADPH Oxidases/genetics ; NADPH Oxidases/metabolism ; Peptide Fragments/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Reactive Oxygen Species/metabolism ; Superoxide Dismutase/metabolism
    Chemical Substances Antineoplastic Agents ; Antioxidants ; Peptide Fragments ; Reactive Oxygen Species ; Malondialdehyde (4Y8F71G49Q) ; Doxorubicin (80168379AG) ; Angiotensin I (9041-90-1) ; Catalase (EC 1.11.1.6) ; Superoxide Dismutase (EC 1.15.1.1) ; NADPH Oxidases (EC 1.6.3.-) ; angiotensin I (1-7) (IJ3FUK8MOF)
    Language English
    Publishing date 2020-02-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00224.2019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Response to "Angiotensin-(1-7) in the central regulation of blood pressure and renin-angiotensin system".

    Varagic, Jasmina / Ferrario, Carlos M

    American journal of hypertension

    2013  Volume 26, Issue 9, Page(s) 1175

    MeSH term(s) Angiotensin I/physiology ; Animals ; Blood Pressure/physiology ; Hypertension/physiopathology ; Male ; Peptide Fragments/physiology ; Proto-Oncogene Proteins/physiology ; Receptor, Angiotensin, Type 1/physiology ; Receptors, G-Protein-Coupled/physiology ; Renin-Angiotensin System/physiology
    Chemical Substances Peptide Fragments ; Proto-Oncogene Proteins ; Receptor, Angiotensin, Type 1 ; Receptors, G-Protein-Coupled ; Angiotensin I (9041-90-1)
    Language English
    Publishing date 2013-08-12
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 639383-4
    ISSN 1941-7225 ; 1879-1905 ; 0895-7061
    ISSN (online) 1941-7225 ; 1879-1905
    ISSN 0895-7061
    DOI 10.1093/ajh/hpt112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Photoacoustic Imaging for the Detection of Hypoxia in the Rat Femoral Artery and Skeletal Muscle Microcirculation.

    Smith, Lane M / Varagic, Jasmina / Yamaleyeva, Liliya M

    Shock (Augusta, Ga.)

    2016  Volume 46, Issue 5, Page(s) 527–530

    Abstract: Photoacoustic (PA) imaging is an emerging technology that combines structural and functional imaging of tissues using laser and ultrasound energy. We evaluated the ability of PA imaging system to measure real-time systemic and microvascular mean oxygen ... ...

    Abstract Photoacoustic (PA) imaging is an emerging technology that combines structural and functional imaging of tissues using laser and ultrasound energy. We evaluated the ability of PA imaging system to measure real-time systemic and microvascular mean oxygen saturation (mSAO2) in a rat model of hypoxic shock. Male Sprague Dawley rats (n = 6) underwent femoral artery catherization and were subjected to acute hypoxia by lowering the fraction of inspired oxygen (FiO2) from 1.0 to 0.21, and then to 0.08. PA measurements of mSaO2 were taken in the femoral artery near the catheter tip using the Vevo 2100 LAZR at each FiO2 and compared to co-oximetry on blood removed from the femoral catheter. Both co-oximetry and PA imaging measured a similar stepwise decline in femoral artery mSaO2 as FiO2 was lowered. We also measured mSaO2 in the feed arteriole of the rat spinotrapezius muscle and adjacent microvessels (n = 6) using PA imaging. A significant decrease in mSaO2 in both the feed arteriole and adjacent microvessels was recorded as FiO2 was decreased from 1.0 to 0.08. Moreover, we detected a rapid return toward baseline mSaO2 in the feed arteriole and microvessels when FiO2 was increased from 0.08 to 1.0. Thus, PA imaging is noninvasive imaging modality that can accurately measure real-time oxygen saturation in the macro and microcirculation during acute hypoxia. This proof-of-concept study is a first step in establishing PA imaging as an investigational tool in critical illness.
    Language English
    Publishing date 2016-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1185432-7
    ISSN 1540-0514 ; 1073-2322
    ISSN (online) 1540-0514
    ISSN 1073-2322
    DOI 10.1097/SHK.0000000000000644
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Apelin-13 in blood pressure regulation and cardiovascular disease.

    Yamaleyeva, Liliya M / Shaltout, Hossam A / Varagic, Jasmina

    Current opinion in nephrology and hypertension

    2016  Volume 25, Issue 5, Page(s) 396–403

    Abstract: Purpose of review: Despite extensive pharmacological treatment, hypertension and heart failure still pose as high health and economic burden. Thus, novel therapeutic approaches are needed to promote more effective treatment of hypertension and ... ...

    Abstract Purpose of review: Despite extensive pharmacological treatment, hypertension and heart failure still pose as high health and economic burden. Thus, novel therapeutic approaches are needed to promote more effective treatment of hypertension and cardiovascular disease. In this review we summarized recent evidence supporting the therapeutic potential of apelin-13, a recently discovered endogenous ligand for the G-protein coupled receptor APJ.
    Recent findings: Systemic administration of apelin-13 or its posttranslationally modified form, pyroglutamate apelin-13, exert vasodilatory and antihypertensive effects. Yet, central application of apelin increases blood pressure and its systemic effects may be compromised in the presence of endothelial dysfunction. In addition, positive inotropic effects by exogenous apelin in the normal and failing heart, as well as cardioprotective effects after myocardial infarction, strongly suggest its therapeutic potential in preventing and treating heart failure and consequences of myocardial ischemia. However, therapeutic use of apelin is limited primarily by its short half-life and parenteral administration, and significant effort has been directed to the development of novel agonists, delivery methods, and improving the efficacy of agonists at APJ.
    Summary: The apelin/APJ axis may represent a new target for the development of novel therapeutic approaches for the treatment of hypertension and cardiovascular disease.
    Language English
    Publishing date 2016-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1151092-4
    ISSN 1473-6543 ; 1535-3842 ; 1062-4813 ; 1062-4821
    ISSN (online) 1473-6543 ; 1535-3842
    ISSN 1062-4813 ; 1062-4821
    DOI 10.1097/MNH.0000000000000241
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Maternal Morbidity and Mortality: Are We Getting to the "Heart" of the Matter?

    Varagic, Jasmina / Desvigne-Nickens, Patrice / Gamble-George, Joyonna / Hollier, Lisa / Maric-Bilkan, Christine / Mitchell, Megan / Pemberton, Victoria L / Redmond, Nicole

    Journal of women's health (2002)

    2020  Volume 30, Issue 2, Page(s) 178–186

    Abstract: Cardiovascular disease (CVD), including hypertensive disorders of pregnancy (HDP) and peripartum cardiomyopathy, is a leading cause of pregnancy-related death in the United States. Women who are African American or American Indian/Alaskan Native, have ... ...

    Abstract Cardiovascular disease (CVD), including hypertensive disorders of pregnancy (HDP) and peripartum cardiomyopathy, is a leading cause of pregnancy-related death in the United States. Women who are African American or American Indian/Alaskan Native, have HDP, are medically underserved, are older, or are obese have a major risk for the onset and/or progression of CVD during and after pregnancy. Paradoxically, women with no preexisting chronic conditions or risk factors also experience significant pregnancy-related cardiovascular (CV) complications. The question remains whether substantial physiologic stress on the CV system during pregnancy reflected in hemodynamic, hematological, and metabolic changes uncovers subclinical prepregnancy CVD in these otherwise healthy women. Equally important and similarly understudied is the concept that women's long-term CV health could be detrimentally affected by adverse pregnancy outcomes, such as preeclampsia, gestational hypertension, and diabetes, and preterm birth. Thus, a critical life span perspective in the assessment of women's CV risk factors is needed to help women and health care providers recognize and appreciate not only optimal CV health but also risk factors present before, during, and after pregnancy. In this review article, we highlight new advancements in understanding adverse, pregnancy-related CV conditions and will discuss promising strategies or interventions for their prevention, diagnosis, and treatment.
    MeSH term(s) Female ; Humans ; Hypertension, Pregnancy-Induced ; Infant, Newborn ; Pre-Eclampsia ; Pregnancy ; Pregnancy Outcome ; Premature Birth ; Risk Factors
    Language English
    Publishing date 2020-12-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1139774-3
    ISSN 1931-843X ; 1059-7115 ; 1540-9996
    ISSN (online) 1931-843X
    ISSN 1059-7115 ; 1540-9996
    DOI 10.1089/jwh.2020.8852
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.

    Varagic, Jasmina / Punzi, Henry / Ferrario, Carlos M

    Integrated blood pressure control

    2014  Volume 7, Page(s) 61–70

    Abstract: Despite significant advances in pharmacologic approaches to treat hypertension during the last decades, hypertension- and hypertension-related organ damage are still a high health and economic burden because a large proportion of patients with ... ...

    Abstract Despite significant advances in pharmacologic approaches to treat hypertension during the last decades, hypertension- and hypertension-related organ damage are still a high health and economic burden because a large proportion of patients with hypertension do not achieve optimal blood pressure control. There is now general agreement that combination therapy with two or more antihypertensive drugs is required for targeted blood pressure accomplishment and reduction of global cardiovascular risk. The goals of combination therapies are to reduce long-term cardiovascular events by targeting different mechanism underlying hypertension and target organ disease, to block the counterregulatory pathways activated by monotherapies, to improve tolerability and decrease the adverse effects of up-titrated single agents, and to increase persistence and adherence with antihypertensive therapy. Multiple clinical trials provide evidence that fixed-dose combinations in a single pill offer several advantages when compared with loose-dose combinations. This review discusses the advances in hypertension control and associated cardiovascular disease as they relate to the prospect of combination therapy targeting a third-generation beta (β) 1-adrenergic receptor (nebivolol) and an angiotensin II receptor blocker (valsartan) in fixed-dose single-pill formulations.
    Language English
    Publishing date 2014-11-26
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2520711-8
    ISSN 1178-7104
    ISSN 1178-7104
    DOI 10.2147/IBPC.S50954
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Body Mass Index, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk.

    Khan, Sadiya S / Petito, Lucia C / Huang, Xiaoning / Harrington, Katharine / McNeil, Rebecca B / Bello, Natalie A / Bairey Merz, C Noel / Miller, Eliza C / Ravi, Rupa / Scifres, Christina / Catov, Janet M / Pemberton, Victoria L / Varagic, Jasmina / Zee, Phyllis C / Yee, Lynn M / Ray, Mitali / Kim, Jin Kyung / Lane-Cordova, Abbi D / Lewey, Jennifer /
    Theilen, Lauren H / Saade, George R / Greenland, Philip / Grobman, William A

    Circulation research

    2023  Volume 133, Issue 9, Page(s) 725–735

    Abstract: Background: Obesity is a well-established risk factor for both adverse pregnancy outcomes (APOs) and cardiovascular disease (CVD). However, it is not known whether APOs are mediators or markers of the obesity-CVD relationship. This study examined the ... ...

    Abstract Background: Obesity is a well-established risk factor for both adverse pregnancy outcomes (APOs) and cardiovascular disease (CVD). However, it is not known whether APOs are mediators or markers of the obesity-CVD relationship. This study examined the association between body mass index, APOs, and postpartum CVD risk factors.
    Methods: The sample included adults from the nuMoM2b (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be) Heart Health Study who were enrolled in their first trimester (6 weeks-13 weeks 6 days gestation) from 8 United States sites. Participants had a follow-up visit at 3.7 years postpartum. APOs, which included hypertensive disorders of pregnancy, preterm birth, small-for-gestational-age birth, and gestational diabetes, were centrally adjudicated. Mediation analyses estimated the association between early pregnancy body mass index and postpartum CVD risk factors (hypertension, hyperlipidemia, and diabetes) and the proportion mediated by each APO adjusted for demographics and baseline health behaviors, psychosocial stressors, and CVD risk factor levels.
    Results: Among 4216 participants enrolled, mean±SD maternal age was 27±6 years. Early pregnancy prevalence of overweight was 25%, and obesity was 22%. Hypertensive disorders of pregnancy occurred in 15%, preterm birth in 8%, small-for-gestational-age birth in 11%, and gestational diabetes in 4%. Early pregnancy obesity, compared with normal body mass index, was associated with significantly higher incidence of postpartum hypertension (adjusted odds ratio, 1.14 [95% CI, 1.10-1.18]), hyperlipidemia (1.11 [95% CI, 1.08-1.14]), and diabetes (1.03 [95% CI, 1.01-1.04]) even after adjustment for baseline CVD risk factor levels. APOs were associated with higher incidence of postpartum hypertension (1.97 [95% CI, 1.61-2.40]) and hyperlipidemia (1.31 [95% CI, 1.03-1.67]). Hypertensive disorders of pregnancy mediated a small proportion of the association between obesity and incident hypertension (13% [11%-15%]) and did not mediate associations with incident hyperlipidemia or diabetes. There was no significant mediation by preterm birth or small-for-gestational-age birth.
    Conclusions: There was heterogeneity across APO subtypes in their association with postpartum CVD risk factors and mediation of the association between early pregnancy obesity and postpartum CVD risk factors. However, only a small or nonsignificant proportion of the association between obesity and CVD risk factors was mediated by any of the APOs, suggesting APOs are a marker of prepregnancy CVD risk and not a predominant cause of postpartum CVD risk.
    MeSH term(s) Pregnancy ; Adult ; Female ; Infant, Newborn ; Humans ; United States ; Young Adult ; Pregnancy Outcome ; Diabetes, Gestational/diagnosis ; Diabetes, Gestational/epidemiology ; Premature Birth/epidemiology ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/epidemiology ; Hypertension, Pregnancy-Induced/diagnosis ; Hypertension, Pregnancy-Induced/epidemiology ; Body Mass Index ; Obesity/diagnosis ; Obesity/epidemiology ; Obesity/complications ; Risk Factors ; Hyperlipidemias/complications
    Language English
    Publishing date 2023-10-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.123.322762
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top